Novartis
This role requires defining biomarker strategies and plans for clinical development projects from early to later stages, translating preclinical discovery into clinical fit-for-purpose plans, and overseeing integration into clinical protocols. The position involves building external collaborations with academia and clinical sites, leading matrixed scientific teams, and interacting with health authorities to advance translational sciences for specific diseases or pathways.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1996
Novartis is an innovative medicines company that pursues scientific breakthroughs to improve and extend people's lives. The company develops and delivers medicines across therapeutic areas including cardiovascular, immunology, neuroscience, and oncology, with its treatments reaching 296 million patients worldwide. With more than 250 years of heritage and 30 years as Novartis, the company works to turn innovations into medicines that redefine the future for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novartis.
34% below the average for this role
Biomarker Experimental Medicine Leader (BEML)
Roche
Biomarker and Precision Medicine Lead
sanofi us
Associate Director, Global Biomarker Lead, Inflammation, GI2 TAU
BioLife Plasma Services
Senior Scientist, Biomarker Strategy
Gilead Sciences
Senior Principal Scientist, Cardiovascular, Translational Development
Bristol Myers Squibb
Clinical Biomarker Lead
Janux Therapeutics